Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
5.97M
-
Shares change
-
+297K
-
Total reported value, excl. options
-
$104M
-
Value change
-
+$5.15M
-
Put/Call ratio
-
0.55
-
Number of buys
-
39
-
Number of sells
-
-27
-
Price
-
$17.41
Significant Holders of PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) as of Q4 2024
88 filings reported holding PLSE - PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share as of Q4 2024.
PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.97M shares
of 69.1M outstanding shares and own 8.63% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1.37M shares), VANGUARD GROUP INC (1.15M shares), BANK OF AMERICA CORP /DE/ (788K shares), STATE STREET CORP (474K shares), GEODE CAPITAL MANAGEMENT, LLC (461K shares), GRIFFIN ASSET MANAGEMENT, INC. (238K shares), Invesco Ltd. (214K shares), NORTHERN TRUST CORP (210K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (149K shares), and MORGAN STANLEY (61.7K shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.